Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07319715Phase 2Completed
Phase 2, randomised, open-label trial of progesterone in preterm birth (3 arms), sponsored by Benha University. Primary endpoint: Success Rate of Treatment Regimens in Preventing Preterm Birth and/or Improving Pregnancy Duration. Started Jan 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07319715.